解读低素B生物合成途径和D-最佳设计,以优化生产
Muath Suliman1, Amr S Bishr2, Khaled M Aboshanab3,4
1Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, King Khalid University, P.O. Box 61413, 9088, Abha, Saudi Arabia.
World journal of microbiology & biotechnology
|April 27, 2025
概括
这项研究通过优化Streptomyces hygroscopicus培养条件来优化Hygromycin B (HYG-B) 生产. 使用D-最佳设计的统计优化显著增加了HYG-B的产量,为工业应用铺平了道路.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 生物化学 生物化学
背景情况:
- 素B (HYG-B) 是一种由Streptomyces hygroscopicus生产的宽谱氨基糖类抗生素.
- 有限的研究存在于HYG-B生物合成和生产优化.
- 了解和增强HYG-B生产对于其治疗应用至关重要.
研究的目的:
- 为了优化环境条件,增强素B的生产.
- 为了阐明Hygromycin B.的生物合成途径.
- 评估抗生素生产的统计优化方法的有效性.
主要方法:
- 一次性一个因素 (OFAT) 方法来研究介质组成和化时间.
- 使用D-最佳设计 (DOD) 来优化pH,温度和振动的响应表面方法.
- 对基因/蛋白质鉴定进行分析,以阐明拟议的生物合成途径.
主要成果:
- OFAT优化确定了最佳介质 (CM6) 和化时间 (7天),使HYG-B.增加了七倍.
- 美国国防部的二次模型优化了初始pH (6.4),温度 (28°C) 和振动 (295rpm).
- 优化条件导致HYG-B产量增加了13倍 (371.5μg/mL),与未优化条件相比.
结论:
- D-最佳设计是优化Hygromycin B生产的有效工具.
- 优化的发酵条件显著提高了Streptomyces hygroscopicus的HYG-B产量.
- 建议在生物反应器中进一步扩大规模,用于工业化生产Hygromycin B.
相关概念视频
Lipid Catabolism
1.4K
Triglycerides serve as crucial long-term energy storage molecules in microorganisms, providing a dense source of metabolic energy. Their breakdown is mediated by lipases, which hydrolyze triglycerides into glycerol and free fatty acids. Each of these components follows distinct metabolic pathways, ultimately contributing to ATP synthesis and cellular energy homeostasis.Glycerol MetabolismGlycerol, released from triglyceride hydrolysis, is phosphorylated by glycerol kinase to form...
1.4K
Biosynthesis in Bacteria
1.0K
Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
1.0K
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Methods of Medium Optimization
70
Optimizing growth media enhances microbial proliferation and maximizes product yield. Statistical experimental design methodologies provide structured and reproducible approaches, offering progressively higher levels of robustness and efficiency.The One-Factor-at-a-Time (OFAT) MethodThe One-Factor-at-a-Time (OFAT) method involves adjusting a single variable while keeping all others constant. However, it cannot detect interactions between variables, often leading to suboptimal outcomes when...
70
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


